SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its community rallies around OG memes and a "return to 2021 vibes," expressing strong conviction and long-term belief in the project. Discussions include potential exchange listings and anticipation for news, alongside general bullishness toward the crypto market. The community emphasizes its relentless building and organic growth.

Lion Group Holding Ltd. operates an all-in-one, state-of-the-art trading platform that offers a wide spectrum of products and services. It operates through the following segments: Futures and Securities Brokerage Services, Contract-For-Difference (CFD) Trading, Total Return Service (TRS) Trading and OTC Stock Option Trading. The company was founded by Jian Wang in 2015 and is headquartered in Singapore.

Lion Group Holding Ltd - ADR

Lion Group Holding Ltd

Lion Group Holding ($LGHL) is trending due to a potential short squeeze, driven by its low float and high borrow rate. Community discussions revolve around its potential for significant gains, drawing comparisons to other recent low-float runners. The company's involvement in crypto, including holding HYPE as a reserve asset, is also fueling interest.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences is trending due to a recent patent allowance, sparking discussions around its potential impact on treatments for mental health disorders. While some traders focus on the underlying science and potential future revenue, others are drawn to the stock's low float and the possibility of a short squeeze, creating a volatile trading environment. Community members are actively debating the company's long-term prospects versus short-term trading opportunities.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions around the company's financials, recent political endorsements, and broader implications for tech and media. Community members are debating the stock's valuation, potential market impact, and its role within the current political climate. The conversation also includes various viewpoints on the performance and future prospects of the company.

Horizon Space Acquisition I Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 14, 2022 and is headquartered in New York, NY.

Horizon Space Acquisition I Corp

HSPO is trending due to a massive, unexpected surge despite the company's voluntary delisting announcement, leading to speculation of a short squeeze. The community is actively discussing the stock's volatility and comparing it to other high-flying SPACs, while some caution against the risks associated with a delisting company.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as investors anticipate upcoming earnings, with analysts highlighting the company's strategic positioning in AI and potential revenue from deals with Microsoft, Google, and Open AI. The community is actively discussing analyst target increases and potential for significant growth, while some traders are cautious about valuation and the possibility of a post-earnings pullback. Discussions also include the potential impact of competition and supply chain dynamics on Broadcom's performance.

Based Beast Coin onboarding the next 1 million users to Base. Collaborating with strong projects on Base while the Based Beast Coin is providing utility via telegram bots services for other projects and members of the base ecosystem. While based beast coin is known for the fans of the Base community we focus on onboarding new users to base and the overall crypto space using collaborations and major rewarding contests.

Based Beast Coin

Based Beast Coin ($BEAST) is trending with community members actively discussing rumors of a connection to Mr. Beast. The coin has seen volatile price action, leading to conversations about potential rug pulls and where to trade the token. Some users report significant gains, while others express skepticism about the coin's long-term viability.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

AFJK is trending due to a massive short squeeze, leading to a parabolic surge and multiple trading halts, with the community actively discussing potential continuation and comparing it to similar past runners. The stock is also associated with a proposed merger with Top Wealth Group, generating speculation about its future prospects. However, caution is advised due to concerns about potential scams and bag holders.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending due to its low float and potential for a short squeeze, with community members actively discussing entry points and price targets. The stock's connection to the metal recycling sector, which is perceived to benefit from certain economic policies, adds another layer of interest. However, some caution against the stock due to concerns about the company's financial filings and past performance.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPM is trending amid discussions around increased expense projections for 2026 and their potential impact on the stock. The community is debating analyst ratings, dividend payouts, and the broader implications of these expenses on JPM's valuation. Additionally, some traders are discussing JPM's involvement in the crypto space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Sonnet BioTherapeutics, Inc. (SONN) soared on Monday after the company entered a definitive business combination agreement with Rorschach I LLC to build a reserve of HYPE, the token of the Hyperliquid Layer-1 blockchain.<a href="https://stocktwits.com/symbol/SONN">SONN shares</a> were trading 82% higher on Monday afternoon at the time of writing.At the closing of the transaction, the newly-created entity is to be named Hyperliquid Strategies Inc. (HSI), which is expected to hold approximately 12.6 million HYPE tokens, representing $583 million in value shortly before agreement signing and gross cash invested of at least $305 million, for a total assumed closing value of $888 million.The gross cash proceeds of $305 million at closing will enable HSI to acquire significantly more HYPE, creating one of the top strategic reserves of the HYPE token, the company said.HSI is expected to remain listed on the Nasdaq under a new ticker symbol and become a public cryptocurrency treasury company upon the closing of the transaction.Sonnet will operate as a wholly-owned subsidiary of HSI and will continue focusing on existing assets and business lines, including the development of its investigational cancer drug SON-1010, while disposing of other assets.Bob Diamond, co-founder and CEO of Atlas Merchant Capital LLC, will be named Chairman of the Board, and David Schamis, CIO and Co-founder of Atlas, will be named Chief Executive Officer of HSI.It is expected that current owners of Rorschach and other new investors at closing will own approximately 98.8% of HSI, and the legacy stockholders of SONN will own the remaining approximately 1.2%.Raghu Rao, interim CEO of Sonnet, said that with the transaction, the company will be able to capitalize on the recent advancements around digital assets and equip Sonnet with funding to potentially realize the future value of its existing biotech assets.Sonnet will also raise an aggregate $5.5 million in a private placement as part of the agreement, which is expected to close on July 14.The business combination agreement is now subject to approval by Sonnet stockholders and other customary closing conditions. The closing of the business combination is expected to occur in the second half of this year.On Stocktwits, retail sentiment around Sonnet is unchanged within ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:625/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_14_at_2_14_50_PM_png_b81036dcad.webp" alt="SONN's Sentiment Meter and Message Volume as of 2:15 p.m. ET on July 14, 2025 | Source: Stocktwits" width="625" height="62"><figcaption>SONN's Sentiment Meter and Message Volume as of 2:15 p.m. ET on July 14, 2025 | Source: Stocktwits</figcaption></figure>SONN stock is up by 545% this year and by 32% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-ceo-transfers-portion-of-holdings-to-ex-wife-as-part-of-divorce-settlement/ch893xvR5nB">Rivian CEO Transfers Portion Of Holdings In EV Maker To Ex-Wife As Part Of Divorce Settlement</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant

Shares of Sonnet BioTherapeutics, Inc. (SONN) soared on Monday after the company entered a definitive business combination agreement with Rorschach I LLC to build a reserve of HYPE

Equity

At the closing of the transaction, the newly created combined entity will be named Hyperliquid Strategies Inc., which is expected to hold approximately 12.6 million HYPE tokens.

Sonnet BioTherapeutics Advances SON-080 into Phase 2 Trials

Sonnet BioTherapeutics Holdings (SONN) just unveiled an update. Promising results from the Phase 1b trial of SON-080 for chemotherapy-induced perip...

Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting

PRINCETON, NJ / ACCESSWIRE / March 19, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ('Sonnet' or the 'Company'), a biopharmaceutical company developing innovative targeted biologic...

Sonnet BioTherapeutics Announces Early Safety Data from the Company's Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study's Initial Pre-Specified Objective

Safety in the Phase 1b part of Sonnet's double-blind, randomized, controlled trial of SON-080 was reviewed by the study's Data Safety Monitoring Board (DSMB)The adverse event profile and tolerability...

Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers

PRINCETON, NJ / ACCESSWIRE / February 29, 2024 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today...

Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update

Successfully raised approximately $4.55 million in gross proceeds through an underwritten public offeringExtensive preclinical data on SON-1210 published in Frontiers in ImmunologyReceived approval...

BTIG Reaffirms Their Buy Rating on Sonnet BioTherapeutics Holdings (SONN)

BTIG analyst Kaveri Pohlman maintained a Buy rating on Sonnet BioTherapeutics Holdings (SONN Research Report) on January 5 and set a price target...

This account has been verified as an official SONN representative.

Verified Account

Sonnet Biotherapeutics

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. It focuses on Fully Human Albumin Binding (FHAB) technology which utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.49	--	--	N/A
Q3 '25	-$0.49	--	--	N/A
Q2 '25	-$0.92	--	--	N/A
Q1 '25	-$1.39	-$1.56	-12.23%	MISSED
Q4 '24	-$5.52	-$3.83	30.62%	BEAT

SONN
Sonnet BioTherapeutics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest SONN News

SONNSonnet BioTherapeutics Holdings Inc